Murae Organisor Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 ,inter alia, to consider and approve Intimation of Board Meeting ....
Awaiting price reaction for this filing.
Murae Organisor Limited (formerly Earum Pharmaceuticals Limited) has informed the BSE that its Board of Directors will meet on April 24, 2025 at its registered office in Ahmedabad. The main item on the agenda is to consider and approve a proposal for sub-division or stock split of the company's equity shares. The exact split ratio has not been disclosed yet and will be decided by the Board, subject to approval from shareholders and other regulatory authorities. This is a preliminary intimation filed under SEBI's listing rules, with further details expected after the board meeting. The stock trades on the BSE under the symbol MURAE (scrip code 542724).
A stock split does not change the total value of a shareholder's investment, but it lowers the per-share price and increases the number of shares held, which can improve liquidity and attract more retail buyers. Investors should watch for the board's final announcement on the split ratio, as it often leads to short-term price movement.